<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The <z:mp ids='MP_0001532'>physiology</z:mp> of counterregulatory responses during <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> in intensively treated type 2 diabetic subjects is largely unknown </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, the specific aims of the study tested the hypothesis that 1) 6 months of intensive therapy to lower A1C &lt;7.0% would blunt autonomic <z:mp ids='MP_0008912'>nervous</z:mp> system (ANS) responses to <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo>, and 2) antecedent <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> will result in counterregulatory failure during subsequent <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> in patients with suboptimal and good glycemic control </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: Fifteen type 2 diabetic patients (8 men/7 women) underwent 6-month combination therapy of <z:chebi fb="0" ids="6801">metformin</z:chebi>, glipizide XL, and <z:chebi fb="0" ids="2376">acarbose</z:chebi> to lower A1C to 6.7% and 2-day repeated hypoglycemic clamp studies before and after intensive therapy </plain></SENT>
<SENT sid="3" pm="."><plain>A control group of eight nondiabetic subjects participated in a single 2-day repeated hypoglycemic clamp study </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Six-month therapy reduced A1C from 10.2 +/- 0.5 to 6.7 +/- 0.3% </plain></SENT>
<SENT sid="5" pm="."><plain>Rates of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> increased to 3.2 episodes per patient/month by study end </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001943'>Hypoglycemia</z:hpo> (3.3 +/- 0.1 mmol/l) and insulinemia (1,722 +/- 198 pmol/l) were similar during <z:hpo ids='HP_0000001'>all</z:hpo> clamp studies </plain></SENT>
<SENT sid="7" pm="."><plain>Intensive therapy reduced (P &lt; 0.05) ANS and metabolic counterregulatory responses during <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Antecedent <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> produced widespread blunting (P &lt; 0.05) of neuroendocrine, ANS, and metabolic counterregulatory responses during subsequent <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> before and after intensive therapy in type 2 diabetic patients and in nondiabetic control subjects </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Intensive oral combination therapy and antecedent <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> both blunt physiological defenses against subsequent <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Prior <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> of only 3.3 +/- 0.1 mmol/l can result in counterregulatory failure in type 2 diabetic patients with suboptimal control and can further impair physiological defenses against <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> in intensively treated type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>